Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
262 SEK | -6.26% | +3.15% | +23.58% |
May. 03 | CellaVision AB Approves the Dividend, Payable on 13 May 2024 | CI |
Apr. 25 | Transcript : CellaVision AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Sales 2024 * | 782M 74.34M | Sales 2025 * | 889M 84.43M | Capitalization | 6.25B 594M |
---|---|---|---|---|---|
Net income 2024 * | 172M 16.34M | Net income 2025 * | 217M 20.62M | EV / Sales 2024 * | 7.81 x |
Net cash position 2024 * | 138M 13.08M | Net cash position 2025 * | 212M 20.17M | EV / Sales 2025 * | 6.79 x |
P/E ratio 2024 * |
36.5
x | P/E ratio 2025 * |
28.8
x | Employees | - |
Yield 2024 * |
0.94% | Yield 2025 * |
1.15% | Free-Float | 82.65% |
Latest transcript on CellaVision AB
1 day | -6.26% | ||
1 week | +3.76% | ||
Current month | +16.19% | ||
1 month | +16.19% | ||
3 months | +2.34% | ||
6 months | +47.86% | ||
Current year | +23.58% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Simon Ostergaard
CEO | Chief Executive Officer | 53 | 21-03-20 |
Magnus Blixt
DFI | Director of Finance/CFO | 58 | 13-05-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Lotta Jarleryd
BRD | Director/Board Member | 58 | 22-05-10 |
Mikael Worning
CHM | Chairman | 62 | 20-04-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 262 | -6.26% | 64,950 |
24-05-30 | 279.5 | +3.14% | 40,995 |
24-05-29 | 271 | +2.85% | 41,536 |
24-05-28 | 263.5 | +3.33% | 17,241 |
24-05-27 | 255 | +0.39% | 10,147 |
Delayed Quote Nasdaq Stockholm, May 31, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.58% | 630M | |
-27.52% | 16.28B | |
-40.04% | 2.96B | |
+15.16% | 1.79B | |
-6.86% | 1.52B | |
+38.67% | 1.33B | |
-15.36% | 968M | |
+3.53% | 840M | |
-26.08% | 833M | |
-24.63% | 619M |
- Stock Market
- Equities
- CEVI Stock